Sirolimus in liver transplantation

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

2002 • 4,016 citations

Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996

2000 • 1,803 citations

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

2002 • 1,717 citations

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

2000 • 922 citations

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

1999 • 886 citations

A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS

2001 • 616 citations

Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells

1995 • 592 citations

Rapamycin inhibits vascular smooth muscle cell migration.

1996 • 504 citations

Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †

1998 • 492 citations

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

1999 • 211 citations

SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATION

1999 • 207 citations

Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma

1998 • 173 citations

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus

2001 • 168 citations

Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients1.

2002 • 157 citations

Liver transplantation using sirolimus and minimal corticosteroids(3-day taper)

2001 • 107 citations

Vascular Endothelial Growth Factor Tightly Regulates In Vivo Development of Murine Hepatocellular Carcinoma Cells

1998 • 102 citations

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus

2001 • 93 citations

Experience with the use of sirolimus in liver transplantation—use in patients for whom calcineurin inhibitors are contraindicated

2000 • 77 citations

Relative Tissue Distributions of Cyclosporine and Sirolimus After Concomitant Peroral Administration to the Rat: Evidence for Pharmacokinetic Interactions

1998 • 68 citations

Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients

2002 • 55 citations

Inhibition by Rapamycin of PDGF- and bFGF-Induced Human Tenon Fibroblast Proliferation in Vitro

1996 • 42 citations

Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results

2001 • 35 citations

Sirolimus (rapamycin)-based rescue treatment following chronic rejection after liver transplantation

2001 • 31 citations

Sirolimus-based immunosuppresive protocol for calcineurin sparing in liver transplantation

2002 • 20 citations